44 results
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
7 Nov 18
Zafgen Reports Third Quarter 2018 Operating and Financial Results
4:15pm
MetAP2 inhibitor,ZGN-1345, to development candidate status. Further, the resurgence of our active engagement with the Prader-Willi community … engagement efficacy. Data from this cohort are on track for topline results in early 2019.
ZGN-1258
Zafgen presented threeZGN-1258 posters
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
25 Jun 18
Zafgen Announces Positive Full Results in Phase 2Proof-of-Concept Trial ofZGN-1061 in Patients withDifficult-to-Control Type 2 Diabetes
7:15am
of effect. The 0.9 mg dose in this trial represents approximately 50% target engagement of MetAP2. These results were well-supported by several relevant
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
14 Sep 22
Other Events
7:05am
, with top-line data expected in 2H 2023.
“We thank the FDA for their engagement and are pleased with their decision to clear CTI-1601’s return
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
8 May 18
Zafgen Reports First Quarter 2018 Operating and Financial Results
4:09pm
on the positive efficacy, safety and tolerability data from this interim analysis, Zafgen has opted to explore the higher end ofZGN-1061’s target engagement
8-K/A
EX-10.1
LRMR
Larimar Therapeutics Inc
29 Sep 20
Departure of Directors or Certain Officers
4:39pm
to continued employment or engagement with the Company or such Affiliate, or (ii) interfere in any way with the right of the Company or such Affiliate … to terminate the employment or engagement of any of its employees or other service providers at any time.
(f) The Awards (whether vested or unvested) shall
8-K
EX-10.1
m65 22j6rqss
29 Sep 20
Departure of Directors or Certain Officers
7:06am
S-1
EX-10.6
ymmjc4excdmvvb3w xu
18 Apr 14
IPO registration
12:00am
S-1
EX-10.10
n2u qmnw7
18 Apr 14
IPO registration
12:00am
S-1
EX-10.8
4thichqj fw
18 Apr 14
IPO registration
12:00am
8-K
EX-10.1
5stry
6 Aug 20
Departure of Directors or Certain Officers
9:00am
8-K
EX-10.4
2xgmio3
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am